BURLINGTON — Dr. Brian Caveney, chief medical officer and president of LabCorp Diagnostics, has been named by Modern Healthcare as one of this year’s “50 Most Influential Clinical Executives.”
Caveney has been among those leading the charge at the Burlington-based life science giant for diagnostic testing in the fight against COVID-19.
“It’s an honor and a privilege to be recognized by my peers for this distinction from Modern Healthcare,” said Caveney, in a statement.
“I am extremely proud of LabCorp’s diagnostics and drug development businesses, which have stood ready to address the COVID-19 situation with increased testing capacity, multiple testing options and clinical research on vaccines and therapies. I am also humbled to work alongside my colleagues, who through science, technology, and delivery, are working to address significant, unmet healthcare needs to improve health and improve lives.”
Founded almost 51 years ago in Burlington, LabCorp operates one of the largest clinical laboratory networks in the world. It is an $11.5 billion business with more than 65,000 employees.
Caveney joined LabCorp after serving as chief medical officer of Blue Cross and Blue Shield of North Carolina (Blue Cross NC). He also served as chief clinical officer of Mosaic Health Solutions, a wholly owned subsidiary of Blue Cross NC for strategic investments in diversified health solutions.
Prior to Blue Cross NC, Dr. Caveney was a practicing physician and assistant professor at Duke University Medical Center. The complete ranking is featured in the June 15 issue of Modern Healthcare.
